Delivered end to end execution of M&A, strategic alliances, joint ventures, and IP licensing including strategy development, pipeline management, diligence, deal structuring, execution and integration planning; drove $150mm in deal value

Built in-depth market intelligence to drive international market expansion; led planning and execution of first ex-US commercialization

Led cross-functional team to negotiate and execute acquisitions, in-licenses, and partnerships with novel life science firms to enhance GRAIL's capabilities in oncology diagnostics

Collaborated with GRAIL leadership and strategic finance teams to execute long-term planning and GRAIL's strategic roadmap through a strategic planning process and ongoing communication with stakeholders

Led cross-functional teams of internal corporate finance and external investment banking advisors to support GRAIL's carve-out into a $500mm public company; presented to private and public equity capital market investors to support

• Lead product development efforts to apply state of the art technologies to novel use cases across the enterprise
• Raise capital for product development initiatives
• Conduct market due-diligence and build pro-forma forecasts to support the investment thesis
• Set the overarching strategy of the Health IT domain within Cleveland Clinic Innovations;

Led corporate transformations, developed digital strategies and operating models, and led commercial due diligence engagements.

Analyzed investments and built portfolios for institutional clients; modeled and forecasted asset class performance; built marketing materials and delivered sales presentations.